Drug comparisons
Chlorpropamide vs Sotagliflozin
Compare Chlorpropamide (sulfonylurea) vs Sotagliflozin (Inpefa) for type 2 diabetes. Key differences in hypoglycemia risk, CV benefits, and mechanisms.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when evaluating older sulfonylureas against newer dual SGLT inhibitors for type 2 diabetes patients, particularly those with heart failure risk.
Bottom line
Sotagliflozin is typically preferred over Chlorpropamide for its superior safety and added cardiovascular benefits in modern diabetes care.
All medication comparisons